IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Halozyme Therapeutics in

CUSIP: 40637HAF6 | TRACE | 144 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Union Bancaire Privee, UBP SA469,999,000
0.0% of portfolio›$197
Citigroup Inc7,005,000
0.0% of portfolio›$13.8M
Absolute Investment Advisers, LLC5,246,000
0.9% of portfolio›$10.3M
Calamos Advisors LLC5,154,000
0.0% of portfolio›$10.2M
Warberg Asset Management LLC5,000,000
1.3% of portfolio›$9.9M
AGF Management LTD750,000
0.0% of portfolio›$1.5M
US Bancorp \de\5,000
0.0% of portfolio›$9.8K
StyleTurnoverLocationFiled
Union Bancaire Privee, UBP SA
469,999,000$1970.0%GrowthMediumGeneva 1, Switzerland2026-11-04
Citigroup Inc
7,005,000$13.8M0.0%CoreMediumNew York, NY2026-11-04
Absolute Investment Advisers, LLC
5,246,000$10.3M0.9%YieldHighRosemary Beach, FL2026-10-21
Calamos Advisors LLC
5,154,000$10.2M0.0%GrowthMediumNaperville, IL2026-11-02
Warberg Asset Management LLC
5,000,000$9.9M1.3%YieldHighWinnetka, IL2026-11-02
AGF Management LTD
750,000$1.5M0.0%GrowthHighToronto, Australia2026-11-03
US Bancorp \de\
5,000$9.8K0.0%IndexLowMinneapolis, MN2026-11-05